Form 4: Director Receives Stock Options at LeonaBio

LeonaBio, Inc. reports that Director Fred Callori was granted stock options for 2,333 shares.

Summary

• Fred Callori, a Director at LeonaBio, Inc., was granted stock options on June 23, 2026.
• The options are for 2,333 shares of common stock.
• The exercise price for these options is $8.35 per share.
• These options are subject to vesting, with full vesting occurring on June 23, 2027, or the day before the next annual stockholder meeting after June 22, 2026.
• The grant is part of the Issuer's Outside Director Compensation Policy and is pro-rated based on Callori's appointment date of May 5, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard compensation event for a director rather than significant financial or strategic news.

Positives

• Director Callori received stock options, aligning his interests with shareholders.
• The grant is structured under the company's established Outside Director Compensation Policy.

Risks

• The value of the stock options is dependent on the future stock price performance of LeonaBio, Inc.
• Vesting conditions mean the options are not immediately exercisable.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a change in beneficial ownership related to stock options.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology sector to incentivize long-term performance and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of options aligns director compensation with potential future stock price appreciation, which can benefit shareholders if the company performs well.

Key Dates

Keywords

LeonaBio, LONA, Form 4, Stock Options, Director Compensation, SEC Filing, Beneficial Ownership